Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF – Get Free Report)’s share price traded up 2.2% during mid-day trading on Wednesday . The stock traded as high as C$2.81 and last traded at C$2.76. 3,101 shares were traded during trading, a decline of 58% from the average session volume of 7,410 shares. The stock had previously closed at C$2.70.
Eupraxia Pharmaceuticals Trading Up 2.2 %
The firm’s fifty day moving average is C$2.63 and its 200-day moving average is C$2.85.
Eupraxia Pharmaceuticals Company Profile
Eupraxia Pharmaceuticals Inc, a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis and eosinophilic esophagitis, as well as under development for treating canine osteoarthritis.
Recommended Stories
- Five stocks we like better than Eupraxia Pharmaceuticals
- What to Know About Investing in Penny Stocks
- How Much Can You Make in Stocks in One Month?
- What is a Special Dividend?
- This Is the Top Large-Cap Stock Insiders Are Buying
- What Are Dividend Champions? How to Invest in the Champions
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Eupraxia Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eupraxia Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
